Determination of ceruloplasmin in human serum by SEC-ICPMS.
This paper describes an analytical method for the determination of ceruloplasmin (Cp) in human serum. The method uses immunoaffinity chromatography and size-exclusion chromatography (SEC) to "purify" the serum sample prior to analysis of 63Cu and 65Cu by inductively-coupled plasma mass spectrometry (ICPMS). By removing the six most abundant proteins from serum with immunoaffinity chromatography and by using SEC to separate Cu bound by Cp from any free Cu that might be present in the serum sample, we demonstrated that SEC-ICPMS can accurately and reproducibly measure Cp in the ERM DA470 reference serum. Cp identification is based on retention time match of the unknown in the serum sample with the Cp external standard and the presence of 63Cu and 65Cu at a ratio of 2.2+/-0.1. This method was used to analyze a reference serum certified for Cp, 47 serum samples from four different diseases and a set of normal controls. The reference serum and a serum sample from a patient with myocardial infarction, as well as a Cp standard, were also analyzed by electrospray mass spectrometry to confirm the presence of Cp in the SEC fraction known to contain 63Cu.
Lopez-Avila
Viorica
V
Agilent Technologies, 5301 Stevens Creek Blvd, Santa Clara, CA 95051, USA. viorica_lopez-avila@agilent.com
Sharpe
Orr
O
Robinson
William H
WH
D001172:Arthritis, Rheumatoid / Q000097:blood; D002138:Calibration; D002570:Ceruloplasmin / Q000032:analysis* / Q000302:isolation & purification; D002846:Chromatography, Affinity; D002850:Chromatography, Gel / Q000295:instrumentation / Q000379:methods*; D003300:Copper / Q000032:analysis; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000097:blood; D013058:Mass Spectrometry / Q000295:instrumentation / Q000379:methods*; D009203:Myocardial Infarction / Q000097:blood; D011655:Pulmonary Embolism / Q000097:blood; D015203:Reproducibility of Results; D044967:Serum / Q000737:chemistry*
D003300:Copper; D002570:Ceruloplasmin